Carina Hage

6PUBLICATIONS
65CO-AUTHORS
Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Oct 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Jan Eckmann, Tanja Fauti, Marlene Biehl

|Mar 04, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

|Nov 17, 2020
Transient commensal clonal interactions can drive tumor metastasis.

Suha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors

|Jun 26, 2020
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody.

Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam

|Jul 11, 2019
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.

Carina Hage, Sabine Hoves, Mailin Ashoff

Pageof 1

Frequent Collaborators

4 joint publications

Christian Klein

2 joint publications

Silvia Jenni

2 joint publications

Marina Bacac

2 joint publications

Johannes Sam